Blood and Blood Components Market Likely to Climb to USD 16.5 Billion By 2031 | OneBlood (US), South African National Blood Service (South Africa), Versiti (US), and Vitalant (US)

The global Blood and Blood Components Market was valued at US$ 12.1 billion in 2021 and it is anticipated to grow up to US$ 16.5 billion by 2031, at a CAGR of 3.1% during the forecast period.

Get Access to A Free Sample Copy of Our Latest Report - https://www.globalinsightservices.com/request-sample/GIS24321

Blood and blood components are used in clinical settings for blood transfusion to save the lives of patients suffering from bleeding disorders, traumatic surgery, chronic diseases, or rare blood diseases. Patients who have been severely injured in car accidents or other traumatic incidents such as violence and assault usually require traumatic surgery. Road accidents cause significant blood loss and hemorrhage, necessitating an immediate blood transfusion to maintain blood volume and save the patient's life.

Furthermore, blood transfusion is required in the treatment of chronic diseases such as blood cancer because cancer treatment involving surgery causes significant blood loss and blood cell loss. Patients undergoing stem cell transplantation for the treatment of blood cancers such as leukemia, myeloma, lymphoma, and others require high doses of chemotherapy, which causes blood cell depletion.

Browse Full Report with TOC- https://www.globalinsightservices.com/reports/blood-and-blood-components-market

Market Drivers and Trends

The increase in cases of chronic diseases among people all over the world is the primary driver of the industry's growth. For example, according to the National Institute of Health, U.S. statistics 2018, approximately 459,058 people have suffered from leukemia, a type of blood cancer, in 2018. The NIH also predicts that approximately 61,090 new cases of leukemia will be diagnosed in the upcoming years. Therefore, the rise in the number of chronic illnesses, such as cancer and liver disease, as well as the large patient pool, is expected to fuel the growth of the blood and blood components market.

Furthermore, the industry's growth will be driven by rising of bleeding disorders and surgeries. The significant increase in the geriatric population, which is susceptible to a variety of chronic diseases such as liver cirrhosis, will drive a high demand for blood derivatives during the period. Rising public awareness of the importance of blood donations, as well as the increasing need for blood and blood derivatives in traumatic patients, are also factors influencing demand for whole blood, which will drive market growth. These factors are expected to drive the growth of the global Blood and Blood Components Market.

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS24321

Major Players in the Global Blood and Blood Components Market

The key players studied in the global Blood and Blood Components Market are Association for the Advancement of Blood & Biotherapies (US), American Red Cross (US), Australian Red Cross (Australia), Carter BloodCare (US), Indian Red Cross (India), National Blood Authority Australia (Australia), OneBlood (US), South African National Blood Service (South Africa), Versiti (US), and Vitalant (US) among others.

COVID-19 Impact

The COVID-19 pandemic and lockdown in various countries around the world has had a negative impact on businesses in all sectors. The COVID-19 pandemic has impacted the entire healthcare supply chain, owing to strict lockdown in several regions. Similarly, the COVID-19 pandemic had a negative impact on the blood and blood component markets due to reduced blood transfusion services due to lockdown. For example, according to an article published in the Journal of Global Health in April 2021, a drop in blood donations of 40% to 67% was observed globally, particularly in countries that had implemented lockdown during the COVID-19 outbreak. According to the same source, the majority of mobile blood donation drives have been cancelled due to an increase in COVID-19 cases.

The number of blood donors and donations has decreased significantly in recent years, particularly during the COVID-19 situation all over the world. Since the beginning of the COVID-19 situation, the American Red Cross has seen a 10% decrease in total donors. Such organizations have faced issues such as staffing shortages and blood drive cancellations.

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS24321

Global Blood and Blood Components Market Segmentation

By Product

Whole Blood
Blood Components

By End-User

Hospitals
Ambulatory surgical centers
Others

By Application

Anemia
Trauma & Surgery
Cancer Treatment
Bleeding Disorders

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.